Ask questions and gain insights about this stock now with Rize AI
OCGN logo

Ocugen, Inc.

OCGN

Stock Analysis

$1.60

+0.00 (+0.00%)• Live

Ocugen, Inc. Analysis Dashboard - Stock Analysis and Financial Metrics

Historical Prices

for Ocugen, Inc.

Key Financial Metrics

for Ocugen, Inc.

2024 FY
P/E Ratio
-5.89
Revenue Growth
-32.82%
EPS Growth
+23.08%
Market Cap
$0.34B
Dividend Yield
0.00%
Debt/Equity
0.26
ROIC
-118.07%
FCF Yield
-15.34%
View additional metrics

Valuation

P/B Ratio21.28
EV/Sales67.47

Financial Health

Current Ratio2.60
Return on Assets-89.17%

Analyst Recommendations

for Ocugen, Inc.

5 analysts
Consensus: Buy

About

for Ocugen, Inc.

Company Details

for Ocugen, Inc.

Sector

Healthcare

Industry

Biotechnology

CEO

Shankar Musunuri

Employees

95

Market Cap

499.69M

Exchange

NASDAQ Capital Market

IPO Date

December 3, 2014

CIK

0001372299

ISIN

US67577C1053

CUSIP

67577C105

Country

US

Balance Sheet

for Ocugen, Inc.

Cash Flow Statement

for Ocugen, Inc.

Income Statement

for Ocugen, Inc.

Rize ist ein KI-gestütztes Investment-Research-Terminal, das eine umfassende Aktienanalyse und Einblicke über ein intuitives Dashboard bietet.

News

No news available at the moment.